1 Study Coverage 1.1 Intravenous Solutions (Colloids) Product Introduction 1.2 Market Segments 1.3 Key Intravenous Solutions (Colloids) Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Intravenous Solutions (Colloids) Market Size Growth Rate by Type 1.4.2 Peripheral Parenteral Nutrition 1.4.3 Total Parenteral Nutrition 1.5 Market by Application 1.5.1 Global Intravenous Solutions (Colloids) Market Size Growth Rate by Application 1.5.2 Hospital & Clinics 1.5.3 Ambulatory 1.5.4 Home Care 1.6 Coronavirus Disease 2019 (Covid-19): Intravenous Solutions (Colloids) Industry Impact 1.6.1 How the Covid-19 is Affecting the Intravenous Solutions (Colloids) Industry 1.6.1.1 Intravenous Solutions (Colloids) Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Intravenous Solutions (Colloids) Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Intravenous Solutions (Colloids) Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Executive Summary 2.1 Global Intravenous Solutions (Colloids) Market Size Estimates and Forecasts 2.1.1 Global Intravenous Solutions (Colloids) Revenue 2015-2026 2.1.2 Global Intravenous Solutions (Colloids) Sales 2015-2026 2.2 Intravenous Solutions (Colloids) Market Size by Region: 2020 Versus 2026 2.2.1 Global Intravenous Solutions (Colloids) Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Intravenous Solutions (Colloids) Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Intravenous Solutions (Colloids) Competitor Landscape by Players 3.1 Intravenous Solutions (Colloids) Sales by Manufacturers 3.1.1 Intravenous Solutions (Colloids) Sales by Manufacturers (2015-2020) 3.1.2 Intravenous Solutions (Colloids) Sales Market Share by Manufacturers (2015-2020) 3.2 Intravenous Solutions (Colloids) Revenue by Manufacturers 3.2.1 Intravenous Solutions (Colloids) Revenue by Manufacturers (2015-2020) 3.2.2 Intravenous Solutions (Colloids) Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Intravenous Solutions (Colloids) Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Intravenous Solutions (Colloids) Revenue in 2019 3.2.5 Global Intravenous Solutions (Colloids) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Intravenous Solutions (Colloids) Price by Manufacturers 3.4 Intravenous Solutions (Colloids) Manufacturing Base Distribution, Product Types 3.4.1 Intravenous Solutions (Colloids) Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Intravenous Solutions (Colloids) Product Type 3.4.3 Date of International Manufacturers Enter into Intravenous Solutions (Colloids) Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Intravenous Solutions (Colloids) Market Size by Type (2015-2020) 4.1.1 Global Intravenous Solutions (Colloids) Sales by Type (2015-2020) 4.1.2 Global Intravenous Solutions (Colloids) Revenue by Type (2015-2020) 4.1.3 Intravenous Solutions (Colloids) Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Intravenous Solutions (Colloids) Market Size Forecast by Type (2021-2026) 4.2.1 Global Intravenous Solutions (Colloids) Sales Forecast by Type (2021-2026) 4.2.2 Global Intravenous Solutions (Colloids) Revenue Forecast by Type (2021-2026) 4.2.3 Intravenous Solutions (Colloids) Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Intravenous Solutions (Colloids) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Breakdown Data by Application (2015-2026) 5.1 Global Intravenous Solutions (Colloids) Market Size by Application (2015-2020) 5.1.1 Global Intravenous Solutions (Colloids) Sales by Application (2015-2020) 5.1.2 Global Intravenous Solutions (Colloids) Revenue by Application (2015-2020) 5.1.3 Intravenous Solutions (Colloids) Price by Application (2015-2020) 5.2 Intravenous Solutions (Colloids) Market Size Forecast by Application (2021-2026) 5.2.1 Global Intravenous Solutions (Colloids) Sales Forecast by Application (2021-2026) 5.2.2 Global Intravenous Solutions (Colloids) Revenue Forecast by Application (2021-2026) 5.2.3 Global Intravenous Solutions (Colloids) Price Forecast by Application (2021-2026) 6 North America 6.1 North America Intravenous Solutions (Colloids) by Country 6.1.1 North America Intravenous Solutions (Colloids) Sales by Country 6.1.2 North America Intravenous Solutions (Colloids) Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Intravenous Solutions (Colloids) Market Facts & Figures by Type 6.3 North America Intravenous Solutions (Colloids) Market Facts & Figures by Application 7 Europe 7.1 Europe Intravenous Solutions (Colloids) by Country 7.1.1 Europe Intravenous Solutions (Colloids) Sales by Country 7.1.2 Europe Intravenous Solutions (Colloids) Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Intravenous Solutions (Colloids) Market Facts & Figures by Type 7.3 Europe Intravenous Solutions (Colloids) Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Intravenous Solutions (Colloids) by Region 8.1.1 Asia Pacific Intravenous Solutions (Colloids) Sales by Region 8.1.2 Asia Pacific Intravenous Solutions (Colloids) Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Intravenous Solutions (Colloids) Market Facts & Figures by Type 8.3 Asia Pacific Intravenous Solutions (Colloids) Market Facts & Figures by Application 9 Latin America 9.1 Latin America Intravenous Solutions (Colloids) by Country 9.1.1 Latin America Intravenous Solutions (Colloids) Sales by Country 9.1.2 Latin America Intravenous Solutions (Colloids) Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Intravenous Solutions (Colloids) Market Facts & Figures by Type 9.3 Central & South America Intravenous Solutions (Colloids) Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Intravenous Solutions (Colloids) by Country 10.1.1 Middle East and Africa Intravenous Solutions (Colloids) Sales by Country 10.1.2 Middle East and Africa Intravenous Solutions (Colloids) Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 UAE 10.2 Middle East and Africa Intravenous Solutions (Colloids) Market Facts & Figures by Type 10.3 Middle East and Africa Intravenous Solutions (Colloids) Market Facts & Figures by Application 11 Company Profiles 11.1 ICU Medical Inc. 11.1.1 ICU Medical Inc. Corporation Information 11.1.2 ICU Medical Inc. Description, Business Overview and Total Revenue 11.1.3 ICU Medical Inc. Sales, Revenue and Gross Margin (2015-2020) 11.1.4 ICU Medical Inc. Intravenous Solutions (Colloids) Products Offered 11.1.5 ICU Medical Inc. Recent Development 11.2 B. Braun Melsungen AG 11.2.1 B. Braun Melsungen AG Corporation Information 11.2.2 B. Braun Melsungen AG Description, Business Overview and Total Revenue 11.2.3 B. Braun Melsungen AG Sales, Revenue and Gross Margin (2015-2020) 11.2.4 B. Braun Melsungen AG Intravenous Solutions (Colloids) Products Offered 11.2.5 B. Braun Melsungen AG Recent Development 11.3 Fresenius Kabi AG 11.3.1 Fresenius Kabi AG Corporation Information 11.3.2 Fresenius Kabi AG Description, Business Overview and Total Revenue 11.3.3 Fresenius Kabi AG Sales, Revenue and Gross Margin (2015-2020) 11.3.4 Fresenius Kabi AG Intravenous Solutions (Colloids) Products Offered 11.3.5 Fresenius Kabi AG Recent Development 11.4 Baxter 11.4.1 Baxter Corporation Information 11.4.2 Baxter Description, Business Overview and Total Revenue 11.4.3 Baxter Sales, Revenue and Gross Margin (2015-2020) 11.4.4 Baxter Intravenous Solutions (Colloids) Products Offered 11.4.5 Baxter Recent Development 11.5 Amanta Healthcare 11.5.1 Amanta Healthcare Corporation Information 11.5.2 Amanta Healthcare Description, Business Overview and Total Revenue 11.5.3 Amanta Healthcare Sales, Revenue and Gross Margin (2015-2020) 11.5.4 Amanta Healthcare Intravenous Solutions (Colloids) Products Offered 11.5.5 Amanta Healthcare Recent Development 11.6 Terumo Medical Corporation 11.6.1 Terumo Medical Corporation Corporation Information 11.6.2 Terumo Medical Corporation Description, Business Overview and Total Revenue 11.6.3 Terumo Medical Corporation Sales, Revenue and Gross Margin (2015-2020) 11.6.4 Terumo Medical Corporation Intravenous Solutions (Colloids) Products Offered 11.6.5 Terumo Medical Corporation Recent Development 11.7 Grifols S.A. 11.7.1 Grifols S.A. Corporation Information 11.7.2 Grifols S.A. Description, Business Overview and Total Revenue 11.7.3 Grifols S.A. Sales, Revenue and Gross Margin (2015-2020) 11.7.4 Grifols S.A. Intravenous Solutions (Colloids) Products Offered 11.7.5 Grifols S.A. Recent Development 11.1 ICU Medical Inc. 11.1.1 ICU Medical Inc. Corporation Information 11.1.2 ICU Medical Inc. Description, Business Overview and Total Revenue 11.1.3 ICU Medical Inc. Sales, Revenue and Gross Margin (2015-2020) 11.1.4 ICU Medical Inc. Intravenous Solutions (Colloids) Products Offered 11.1.5 ICU Medical Inc. Recent Development 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Intravenous Solutions (Colloids) Market Estimates and Projections by Region 12.1.1 Global Intravenous Solutions (Colloids) Sales Forecast by Regions 2021-2026 12.1.2 Global Intravenous Solutions (Colloids) Revenue Forecast by Regions 2021-2026 12.2 North America Intravenous Solutions (Colloids) Market Size Forecast (2021-2026) 12.2.1 North America: Intravenous Solutions (Colloids) Sales Forecast (2021-2026) 12.2.2 North America: Intravenous Solutions (Colloids) Revenue Forecast (2021-2026) 12.2.3 North America: Intravenous Solutions (Colloids) Market Size Forecast by Country (2021-2026) 12.3 Europe Intravenous Solutions (Colloids) Market Size Forecast (2021-2026) 12.3.1 Europe: Intravenous Solutions (Colloids) Sales Forecast (2021-2026) 12.3.2 Europe: Intravenous Solutions (Colloids) Revenue Forecast (2021-2026) 12.3.3 Europe: Intravenous Solutions (Colloids) Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Intravenous Solutions (Colloids) Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Intravenous Solutions (Colloids) Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Intravenous Solutions (Colloids) Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Intravenous Solutions (Colloids) Market Size Forecast by Region (2021-2026) 12.5 Latin America Intravenous Solutions (Colloids) Market Size Forecast (2021-2026) 12.5.1 Latin America: Intravenous Solutions (Colloids) Sales Forecast (2021-2026) 12.5.2 Latin America: Intravenous Solutions (Colloids) Revenue Forecast (2021-2026) 12.5.3 Latin America: Intravenous Solutions (Colloids) Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Intravenous Solutions (Colloids) Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Intravenous Solutions (Colloids) Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Intravenous Solutions (Colloids) Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Intravenous Solutions (Colloids) Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter’s Five Forces Analysis 13.5 Primary Interviews with Key Intravenous Solutions (Colloids) Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Intravenous Solutions (Colloids) Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details

List of Tables Table 1. Intravenous Solutions (Colloids) Market Segments Table 2. Ranking of Global Top Intravenous Solutions (Colloids) Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Intravenous Solutions (Colloids) Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of Peripheral Parenteral Nutrition Table 5. Major Manufacturers of Total Parenteral Nutrition Table 6. COVID-19 Impact Global Market: (Four Intravenous Solutions (Colloids) Market Size Forecast Scenarios) Table 7. Opportunities and Trends for Intravenous Solutions (Colloids) Players in the COVID-19 Landscape Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 9. Key Regions/Countries Measures against Covid-19 Impact Table 10. Proposal for Intravenous Solutions (Colloids) Players to Combat Covid-19 Impact Table 11. Global Intravenous Solutions (Colloids) Market Size Growth Rate by Application 2020-2026 (K Units) Table 12. Global Intravenous Solutions (Colloids) Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 13. Global Intravenous Solutions (Colloids) Sales by Regions 2015-2020 (K Units) Table 14. Global Intravenous Solutions (Colloids) Sales Market Share by Regions (2015-2020) Table 15. Global Intravenous Solutions (Colloids) Revenue by Regions 2015-2020 (US$ Million) Table 16. Global Intravenous Solutions (Colloids) Sales by Manufacturers (2015-2020) (K Units) Table 17. Global Intravenous Solutions (Colloids) Sales Share by Manufacturers (2015-2020) Table 18. Global Intravenous Solutions (Colloids) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 19. Global Intravenous Solutions (Colloids) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Solutions (Colloids) as of 2019) Table 20. Intravenous Solutions (Colloids) Revenue by Manufacturers (2015-2020) (US$ Million) Table 21. Intravenous Solutions (Colloids) Revenue Share by Manufacturers (2015-2020) Table 22. Key Manufacturers Intravenous Solutions (Colloids) Price (2015-2020) (USD/Unit) Table 23. Intravenous Solutions (Colloids) Manufacturers Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Intravenous Solutions (Colloids) Product Type Table 25. Date of International Manufacturers Enter into Intravenous Solutions (Colloids) Market Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans Table 27. Global Intravenous Solutions (Colloids) Sales by Type (2015-2020) (K Units) Table 28. Global Intravenous Solutions (Colloids) Sales Share by Type (2015-2020) Table 29. Global Intravenous Solutions (Colloids) Revenue by Type (2015-2020) (US$ Million) Table 30. Global Intravenous Solutions (Colloids) Revenue Share by Type (2015-2020) Table 31. Intravenous Solutions (Colloids) Average Selling Price (ASP) by Type 2015-2020 (USD/Unit) Table 32. Global Intravenous Solutions (Colloids) Sales by Application (2015-2020) (K Units) Table 33. Global Intravenous Solutions (Colloids) Sales Share by Application (2015-2020) Table 34. North America Intravenous Solutions (Colloids) Sales by Country (2015-2020) (K Units) Table 35. North America Intravenous Solutions (Colloids) Sales Market Share by Country (2015-2020) Table 36. North America Intravenous Solutions (Colloids) Revenue by Country (2015-2020) (US$ Million) Table 37. North America Intravenous Solutions (Colloids) Revenue Market Share by Country (2015-2020) Table 38. North America Intravenous Solutions (Colloids) Sales by Type (2015-2020) (K Units) Table 39. North America Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020) Table 40. North America Intravenous Solutions (Colloids) Sales by Application (2015-2020) (K Units) Table 41. North America Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020) Table 42. Europe Intravenous Solutions (Colloids) Sales by Country (2015-2020) (K Units) Table 43. Europe Intravenous Solutions (Colloids) Sales Market Share by Country (2015-2020) Table 44. Europe Intravenous Solutions (Colloids) Revenue by Country (2015-2020) (US$ Million) Table 45. Europe Intravenous Solutions (Colloids) Revenue Market Share by Country (2015-2020) Table 46. Europe Intravenous Solutions (Colloids) Sales by Type (2015-2020) (K Units) Table 47. Europe Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020) Table 48. Europe Intravenous Solutions (Colloids) Sales by Application (2015-2020) (K Units) Table 49. Europe Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020) Table 50. Asia Pacific Intravenous Solutions (Colloids) Sales by Region (2015-2020) (K Units) Table 51. Asia Pacific Intravenous Solutions (Colloids) Sales Market Share by Region (2015-2020) Table 52. Asia Pacific Intravenous Solutions (Colloids) Revenue by Region (2015-2020) (US$ Million) Table 53. Asia Pacific Intravenous Solutions (Colloids) Revenue Market Share by Region (2015-2020) Table 54. Asia Pacific Intravenous Solutions (Colloids) Sales by Type (2015-2020) (K Units) Table 55. Asia Pacific Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020) Table 56. Asia Pacific Intravenous Solutions (Colloids) Sales by Application (2015-2020) (K Units) Table 57. Asia Pacific Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020) Table 58. Latin America Intravenous Solutions (Colloids) Sales by Country (2015-2020) (K Units) Table 59. Latin America Intravenous Solutions (Colloids) Sales Market Share by Country (2015-2020) Table 60. Latin Americaa Intravenous Solutions (Colloids) Revenue by Country (2015-2020) (US$ Million) Table 61. Latin America Intravenous Solutions (Colloids) Revenue Market Share by Country (2015-2020) Table 62. Latin America Intravenous Solutions (Colloids) Sales by Type (2015-2020) (K Units) Table 63. Latin America Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020) Table 64. Latin America Intravenous Solutions (Colloids) Sales by Application (2015-2020) (K Units) Table 65. Latin America Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020) Table 66. Middle East and Africa Intravenous Solutions (Colloids) Sales by Country (2015-2020) (K Units) Table 67. Middle East and Africa Intravenous Solutions (Colloids) Sales Market Share by Country (2015-2020) Table 68. Middle East and Africa Intravenous Solutions (Colloids) Revenue by Country (2015-2020) (US$ Million) Table 69. Middle East and Africa Intravenous Solutions (Colloids) Revenue Market Share by Country (2015-2020) Table 70. Middle East and Africa Intravenous Solutions (Colloids) Sales by Type (2015-2020) (K Units) Table 71. Middle East and Africa Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020) Table 72. Middle East and Africa Intravenous Solutions (Colloids) Sales by Application (2015-2020) (K Units) Table 73. Middle East and Africa Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020) Table 74. ICU Medical Inc. Corporation Information Table 75. ICU Medical Inc. Description and Major Businesses Table 76. ICU Medical Inc. Intravenous Solutions (Colloids) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 77. ICU Medical Inc. Product Table 78. ICU Medical Inc. Recent Development Table 79. B. Braun Melsungen AG Corporation Information Table 80. B. Braun Melsungen AG Description and Major Businesses Table 81. B. Braun Melsungen AG Intravenous Solutions (Colloids) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 82. B. Braun Melsungen AG Product Table 83. B. Braun Melsungen AG Recent Development Table 84. Fresenius Kabi AG Corporation Information Table 85. Fresenius Kabi AG Description and Major Businesses Table 86. Fresenius Kabi AG Intravenous Solutions (Colloids) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 87. Fresenius Kabi AG Product Table 88. Fresenius Kabi AG Recent Development Table 89. Baxter Corporation Information Table 90. Baxter Description and Major Businesses Table 91. Baxter Intravenous Solutions (Colloids) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 92. Baxter Product Table 93. Baxter Recent Development Table 94. Amanta Healthcare Corporation Information Table 95. Amanta Healthcare Description and Major Businesses Table 96. Amanta Healthcare Intravenous Solutions (Colloids) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 97. Amanta Healthcare Product Table 98. Amanta Healthcare Recent Development Table 99. Terumo Medical Corporation Corporation Information Table 100. Terumo Medical Corporation Description and Major Businesses Table 101. Terumo Medical Corporation Intravenous Solutions (Colloids) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 102. Terumo Medical Corporation Product Table 103. Terumo Medical Corporation Recent Development Table 104. Grifols S.A. Corporation Information Table 105. Grifols S.A. Description and Major Businesses Table 106. Grifols S.A. Intravenous Solutions (Colloids) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 107. Grifols S.A. Product Table 108. Grifols S.A. Recent Development Table 109. Global Intravenous Solutions (Colloids) Sales Forecast by Regions (2021-2026) (K Units) Table 110. Global Intravenous Solutions (Colloids) Sales Market Share Forecast by Regions (2021-2026) Table 111. Global Intravenous Solutions (Colloids) Revenue Forecast by Regions (2021-2026) (US$ Million) Table 112. Global Intravenous Solutions (Colloids) Revenue Market Share Forecast by Regions (2021-2026) Table 113. North America: Intravenous Solutions (Colloids) Sales Forecast by Country (2021-2026) (K Units) Table 114. North America: Intravenous Solutions (Colloids) Revenue Forecast by Country (2021-2026) (US$ Million) Table 115. Europe: Intravenous Solutions (Colloids) Sales Forecast by Country (2021-2026) (K Units) Table 116. Europe: Intravenous Solutions (Colloids) Revenue Forecast by Country (2021-2026) (US$ Million) Table 117. Asia Pacific: Intravenous Solutions (Colloids) Sales Forecast by Region (2021-2026) (K Units) Table 118. Asia Pacific: Intravenous Solutions (Colloids) Revenue Forecast by Region (2021-2026) (US$ Million) Table 119. Latin America: Intravenous Solutions (Colloids) Sales Forecast by Country (2021-2026) (K Units) Table 120. Latin America: Intravenous Solutions (Colloids) Revenue Forecast by Country (2021-2026) (US$ Million) Table 121. Middle East and Africa: Intravenous Solutions (Colloids) Sales Forecast by Country (2021-2026) (K Units) Table 122. Middle East and Africa: Intravenous Solutions (Colloids) Revenue Forecast by Country (2021-2026) (US$ Million) Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 124. Key Challenges Table 125. Market Risks Table 126. Main Points Interviewed from Key Intravenous Solutions (Colloids) Players Table 127. Intravenous Solutions (Colloids) Customers List Table 128. Intravenous Solutions (Colloids) Distributors List Table 129. Research Programs/Design for This Report Table 130. Key Data Information from Secondary Sources Table 131. Key Data Information from Primary Sources List of Figures Figure 1. Intravenous Solutions (Colloids) Product Picture Figure 2. Global Intravenous Solutions (Colloids) Sales Market Share by Type in 2020 & 2026 Figure 3. Peripheral Parenteral Nutrition Product Picture Figure 4. Total Parenteral Nutrition Product Picture Figure 5. Global Intravenous Solutions (Colloids) Sales Market Share by Application in 2020 & 2026 Figure 6. Hospital & Clinics Figure 7. Ambulatory Figure 8. Home Care Figure 9. Intravenous Solutions (Colloids) Report Years Considered Figure 10. Global Intravenous Solutions (Colloids) Market Size 2015-2026 (US$ Million) Figure 11. Global Intravenous Solutions (Colloids) Sales 2015-2026 (K Units) Figure 12. Global Intravenous Solutions (Colloids) Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Global Intravenous Solutions (Colloids) Sales Market Share by Region (2015-2020) Figure 14. Global Intravenous Solutions (Colloids) Sales Market Share by Region in 2019 Figure 15. Global Intravenous Solutions (Colloids) Revenue Market Share by Region (2015-2020) Figure 16. Global Intravenous Solutions (Colloids) Revenue Market Share by Region in 2019 Figure 17. Global Intravenous Solutions (Colloids) Sales Share by Manufacturer in 2019 Figure 18. The Top 10 and 5 Players Market Share by Intravenous Solutions (Colloids) Revenue in 2019 Figure 19. Intravenous Solutions (Colloids) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 20. Global Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020) Figure 21. Global Intravenous Solutions (Colloids) Sales Market Share by Type in 2019 Figure 22. Global Intravenous Solutions (Colloids) Revenue Market Share by Type (2015-2020) Figure 23. Global Intravenous Solutions (Colloids) Revenue Market Share by Type in 2019 Figure 24. Global Intravenous Solutions (Colloids) Market Share by Price Range (2015-2020) Figure 25. Global Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020) Figure 26. Global Intravenous Solutions (Colloids) Sales Market Share by Application in 2019 Figure 27. Global Intravenous Solutions (Colloids) Revenue Market Share by Application (2015-2020) Figure 28. Global Intravenous Solutions (Colloids) Revenue Market Share by Application in 2019 Figure 29. North America Intravenous Solutions (Colloids) Sales Growth Rate 2015-2020 (K Units) Figure 30. North America Intravenous Solutions (Colloids) Revenue Growth Rate 2015-2020 (US$ Million) Figure 31. North America Intravenous Solutions (Colloids) Sales Market Share by Country in 2019 Figure 32. North America Intravenous Solutions (Colloids) Revenue Market Share by Country in 2019 Figure 33. U.S. Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 34. U.S. Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Canada Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 36. Canada Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. North America Intravenous Solutions (Colloids) Market Share by Type in 2019 Figure 38. North America Intravenous Solutions (Colloids) Market Share by Application in 2019 Figure 39. Europe Intravenous Solutions (Colloids) Sales Growth Rate 2015-2020 (K Units) Figure 40. Europe Intravenous Solutions (Colloids) Revenue Growth Rate 2015-2020 (US$ Million) Figure 41. Europe Intravenous Solutions (Colloids) Sales Market Share by Country in 2019 Figure 42. Europe Intravenous Solutions (Colloids) Revenue Market Share by Country in 2019 Figure 43. Germany Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 44. Germany Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. France Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 46. France Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. U.K. Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 48. U.K. Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Italy Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 50. Italy Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Russia Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 52. Russia Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Europe Intravenous Solutions (Colloids) Market Share by Type in 2019 Figure 54. Europe Intravenous Solutions (Colloids) Market Share by Application in 2019 Figure 55. Asia Pacific Intravenous Solutions (Colloids) Sales Growth Rate 2015-2020 (K Units) Figure 56. Asia Pacific Intravenous Solutions (Colloids) Revenue Growth Rate 2015-2020 (US$ Million) Figure 57. Asia Pacific Intravenous Solutions (Colloids) Sales Market Share by Region in 2019 Figure 58. Asia Pacific Intravenous Solutions (Colloids) Revenue Market Share by Region in 2019 Figure 59. China Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 60. China Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Japan Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 62. Japan Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. South Korea Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 64. South Korea Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. India Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 66. India Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Australia Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 68. Australia Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Taiwan Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 70. Taiwan Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Indonesia Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 72. Indonesia Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Thailand Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 74. Thailand Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Malaysia Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 76. Malaysia Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Philippines Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 78. Philippines Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Vietnam Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 80. Vietnam Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Asia Pacific Intravenous Solutions (Colloids) Market Share by Type in 2019 Figure 82. Asia Pacific Intravenous Solutions (Colloids) Market Share by Application in 2019 Figure 83. Latin America Intravenous Solutions (Colloids) Sales Growth Rate 2015-2020 (K Units) Figure 84. Latin America Intravenous Solutions (Colloids) Revenue Growth Rate 2015-2020 (US$ Million) Figure 85. Latin America Intravenous Solutions (Colloids) Sales Market Share by Country in 2019 Figure 86. Latin America Intravenous Solutions (Colloids) Revenue Market Share by Country in 2019 Figure 87. Mexico Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 88. Mexico Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 89. Brazil Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 90. Brazil Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 91. Argentina Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 92. Argentina Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 93. Latin America Intravenous Solutions (Colloids) Market Share by Type in 2019 Figure 94. Latin America Intravenous Solutions (Colloids) Market Share by Application in 2019 Figure 95. Middle East and Africa Intravenous Solutions (Colloids) Sales Growth Rate 2015-2020 (K Units) Figure 96. Middle East and Africa Intravenous Solutions (Colloids) Revenue Growth Rate 2015-2020 (US$ Million) Figure 97. Middle East and Africa Intravenous Solutions (Colloids) Sales Market Share by Country in 2019 Figure 98. Middle East and Africa Intravenous Solutions (Colloids) Revenue Market Share by Country in 2019 Figure 99. Turkey Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 100. Turkey Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 101. Saudi Arabia Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 102. Saudi Arabia Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 103. UAE Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 104. UAE Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 105. Middle East and Africa Intravenous Solutions (Colloids) Market Share by Type in 2019 Figure 106. Middle East and Africa Intravenous Solutions (Colloids) Market Share by Application in 2019 Figure 107. ICU Medical Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 108. B. Braun Melsungen AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 109. Fresenius Kabi AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 110. Baxter Total Revenue (US$ Million): 2019 Compared with 2018 Figure 111. Amanta Healthcare Total Revenue (US$ Million): 2019 Compared with 2018 Figure 112. Terumo Medical Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 113. Grifols S.A. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 114. North America Intravenous Solutions (Colloids) Sales Growth Rate Forecast (2021-2026) (K Units) Figure 115. North America Intravenous Solutions (Colloids) Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 116. Europe Intravenous Solutions (Colloids) Sales Growth Rate Forecast (2021-2026) (K Units) Figure 117. Europe Intravenous Solutions (Colloids) Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 118. Asia Pacific Intravenous Solutions (Colloids) Sales Growth Rate Forecast (2021-2026) (K Units) Figure 119. Asia Pacific Intravenous Solutions (Colloids) Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 120. Latin America Intravenous Solutions (Colloids) Sales Growth Rate Forecast (2021-2026) (K Units) Figure 121. Latin America Intravenous Solutions (Colloids) Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 122. Middle East and Africa Intravenous Solutions (Colloids) Sales Growth Rate Forecast (2021-2026) (K Units) Figure 123. Middle East and Africa Intravenous Solutions (Colloids) Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 124. Porter's Five Forces Analysis Figure 125. Channels of Distribution Figure 126. Distributors Profiles Figure 127. Bottom-up and Top-down Approaches for This Report Figure 128. Data Triangulation Figure 129. Key Executives Interviewed

ICU Medical Inc. B. Braun Melsungen AG Fresenius Kabi AG Baxter Amanta Healthcare Terumo Medical Corporation Grifols S.A.